Pharmaceuticals / Sleep Disorders
Lilly to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Disorder Treatments
Eli Lilly and Company is set to acquire Centessa Pharmaceuticals for a potential total of $7.8 billion. This acquisition aims to advance treatments for sleep-wake disorders by leveraging Centessa's orexin receptor 2 (OX2R) agonists, which h...